U.S. market Closed. Opens in 24 minutes

SNY | Sanofi Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for SNY we got that it has average fundamentals where Valuation is considered to be significantly undervalued, Profitability is very poor, Growth is very good and Health is passable.

Valuation (83%)

Company Industry
P/E Ratio (TTM) 15.78 47.95
PEG Ratio (TTM) 1.35 2.46
P/S Ratio (TTM) 1.84 8.64
P/B Ratio (TTM) 1.71 25.08
P/FCF Ratio (TTM) 30.55 -43.16
Price to 5YR AVG Earnings Ratio 19.24 59.12
Price to 5YR AVG FCF Ratio 19.24 88.29

Profitability (40%)

Company Industry
ROA (TTM) 6.07% 6.64%
ROE (TTM) 10.71% 31.96%
Net Profit Margin (TTM) 11.60% 13.51%
ROIC 5YR AVG 11.38% 20.64%

Growth (75%)

4QTR AVG 3YR AVG 5YR AVG
EPS 27.08% 76.38% 45.57%
Revenue 34.61% 3.21% 4.07%
Net Income 27.43% 86.99% 52.00%
Cash Flow -50.00% 25.69% 14.91%

Health (51%)

Company Industry
Current Ratio (TTM) 1.00 1.10
Quick Ratio (TTM) 0.65 0.87
D/E Ratio (TTM) 0.30 3.29
Interest Coverage (TTM) 10.13 14.88
Piotroski F-Score 6 6
Altman Z-Score 2.94 4.76
LTL to 5YR AVG FCF 2.05 4.06
Shares Outstanding Growth 5YR AVG 19.85% 1.17%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙